Page 16 - Read Online

Page 10 of 10 Wang et al. Hepatoma Res 2018;4:14 I http://dx.doi.org/10.20517/2394-5079.2018.16

carcinoma. Hepatogastroenterology 2013;60:28-31.
68. Nojiri K, Tanaka K, Takeda K, Ueda M, Matsuyama R, Taniguchi K, Kumamoto T, Mori R, Endo I. The efficacy of liver resection for
multinodular hepatocellular carcinoma. Anticancer Res 2014;34:2421-6.
69. Govindarajan S, Craig JR, Valinluck B. Clonal origin of hepatitis B virus-associated hepatocellular carcinoma. Hum Pathol
1988;19:403-5.
70. Aoki N, Robinson WS. State of hepatitis B viral genomes in cirrhotic and hepatocellular carcinoma nodules. Mol Biol Med 1989;6:395-
408.
71. Nomoto S, Kinoshita T, Kato K, Otani S, Kasuya H, Takeda S, Kanazumi N, Sugimoto H, Nakao A. Hypermethylation of multiple
genes as clonal markers in multicentric hepatocellular carcinoma. Br J Cancer 2007;97:1260-5.
72. Sirivatanauksorn Y, Sirivatanauksorn V, Bhattacharya S, Davidson BR, Dhillon AP, Kakkar AK, Williamson RC, Lemoine NR. Genomic
heterogeneity in synchronous hepatocellular carcinomas. Gut 1999;45:761-5.
73. Nomoto S, Yamashita K, Koshikawa K, Nakao A, Sidransky D. Mitochondrial D-loop mutations as clonal markers in multicentric
hepatocellular carcinoma and plasma. Clin Cancer Res 2002;8:481-7.
74. Okuda T, Wakasa K, Kubo S, Hamada T, Fujita M, Enomoto T, Haba T, Hirohashi K, Kinoshita H. Clonal analysis of hepatocellular
carcinoma and dysplastic nodule by methylation pattern of X-chromosome-linked human androgen receptor gene. Cancer Letters
2001;164:91-6.
75. Hsu HC, Chiou TJ, Chen JY, Lee CS, Lee PH, Peng SY. Clonality and clonal evolution of hepatocellular carcinoma with multiple
nodules. Hepatology 1991;13:923-8.
76. Tsuda H, Oda T, Sakamoto M, Hirohashi S. Different pattern of chromosomal allele loss in multiple hepatocellular carcinomas as
evidence of their multifocal origin. Cancer Res 1992;52:1504-9.
77. Hui AM, Kawasaki S, Imamura H, Miyagawa S, Ishii K, Katsuyama T, Makuuchi M. Heterogeneity of DNA content in multiple
synchronous hepatocellular carcinomas. Br J Cancer 1997;76:335-9.
78. Furuta M, Ueno M, Fujimoto A, Hayami S, Yasukawa S, Kojima F, Arihiro K, Kawakami Y, Wardell CP, Shiraishi Y, Tanaka H, Nakano K,
Maejima K, Sasaki-Oku A, Tokunaga N, Boroevich KA, Abe T, Aikata H, Ohdan H, Gotoh K, Kubo M, Tsunoda T, Miyano S, Chayama
K, Yamaue H, Nakagawa H. Whole genome sequencing discriminates hepatocellular carcinoma with intrahepatic metastasis from multi-
centric tumors. J Hepatol 2017;66:363-73.
79. Lin DC, Mayakonda A, Dinh HQ, Huang P, Lin L, Liu X, Ding LW, Wang J, Berman BP, Song EW, Yin D, Koeffler HP. Genomic and
epigenomic heterogeneity of hepatocellular carcinoma. Cancer Res 2017;77:2255-65.
80. Ng IO, Guan XY, Poon RT, Fan ST, Lee JM. Determination of the molecular relationship between multiple tumour nodules in
hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis. J Pathol 2003;199:345-53.
81. Hodges KB, Cummings OW, Saxena R, Wang M, Zhang S, Lopez-Beltran A, Montironi R, Nour H, Cheng L. Clonal origin of
multifocal hepatocellular carcinoma. Cancer 2010;116:4078-85.
82. Zhao Q, Su CQ, Dong H, Lu XY, Wu MC, Cong WM. Hepatocellular carcinoma and hepatic adenocarcinosarcoma in a patient with
hepatitis B virus-related cirrhosis. Semin Liver Dis 2010;30:107-12.
83. Zhao Q, Yu WL, Lu XY, Dong H, Gu YJ, Sheng X, Cong WM, Wu MC. Combined hepatocellular and cholangiocarcinoma originating
from the same clone: a pathomolecular evidence-based study. Chin J Cancer 2016;35:82.